Swoop is an AI-driven predictive audience targeting platform for pharma commercialization.
Swoop is a healthcare marketing platform that uses AI-driven predictive targeting to identify and activate patient and HCP audiences for pharmaceutical commercialization. The platform operates 62+ condition-specific patient communities and applies its patented predictive AI methodology across five key patient-journey inflection points: undiagnosed, rapid adopters, formulary, adherence, and progression. Swoop offers a full self-service demand-side platform for omnichannel healthcare advertising.
Spun off from Real Chemistry in September 2024 and now backed by New Mountain Capital as an independent company, Swoop processes 300M+ de-identified patient journeys through its Zero-Knowledge Methodology for HIPAA-compliant audience targeting. The platform differentiates from competitors like Pathwai through its established patient community network and full DSP capabilities, whereas Pathwai focuses on transformer-based audience identification and activation rather than programmatic media buying.
